MTOR and hepatocellular carcinoma: The data showed that the major altered pathways in HCC cells with acquired sorafenib resistance included the gap junction, regulation of cytoskeleton, focal adhesion, adherens junction, mammalian target of rapamycin (mTOR) signaling, MAPK signaling, and Rap1 signaling pathways.